ROCK2 and central nervous system cancer: In fact, we revealed that treatment with the ROCK inhibitor Y27632 led to a decrease in MLC-P levels (Figure 8c) which indicates that ROCK2 is involved in the development of the membrane protrusions occurring in the U343-MG and U373-MG glioma cells with knockdown of SOX2.